Recombinant Human GLRX Protein，His

GLRX, or Glutaredoxin, is a crucial member of the thioredoxin superfamily and plays a significant role in maintaining cellular redox balance by catalyzing the reduction of oxidized proteins and protecting cells from oxidative stress. The interest in recombinant GLRX protein has surged due to its implications in various biological processes, including cellular signaling, apoptosis, and the regulation of cellular metabolism. Abnormal GLRX expression has been linked to several diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases, making it a potential biomarker and therapeutic target. Research into recombinant GLRX focuses on the protein's structure and function to better understand its mechanisms and interactions within the cell. Furthermore, producing GLRX in a recombinant form allows for extensive studies on its enzymatic activities, potential inhibitors, and its role in redox biology, paving the way for novel therapeutic approaches. Advances in biotechnology have enabled the efficient expression and purification of GLRX, facilitating a range of studies that contribute to our understanding of its physiological roles and applications in medicine. As such, the exploration of GLRX through recombinant technology represents an important avenue for improving our knowledge of oxidative stress management and developing therapeutic strategies for redox-related diseases.